Search for other papers by Rachel D C A Diniz in
Google Scholar
PubMed
Search for other papers by Renata M Souza in
Google Scholar
PubMed
Search for other papers by Roberto Salvatori in
Google Scholar
PubMed
Search for other papers by Alex Franca in
Google Scholar
PubMed
Search for other papers by Elenilde Gomes-Santos in
Google Scholar
PubMed
Search for other papers by Thiago O Ferrão in
Google Scholar
PubMed
Search for other papers by Carla R P Oliveira in
Google Scholar
PubMed
Search for other papers by João A M Santana in
Google Scholar
PubMed
Search for other papers by Francisco A Pereira in
Google Scholar
PubMed
Search for other papers by Rita A A Barbosa in
Google Scholar
PubMed
Search for other papers by Anita H O Souza in
Google Scholar
PubMed
Search for other papers by Rossana M C Pereira in
Google Scholar
PubMed
Search for other papers by Alécia A Oliveira-Santos in
Google Scholar
PubMed
Search for other papers by Allysson M P Silva in
Google Scholar
PubMed
Search for other papers by Francisco J Santana-Júnior in
Google Scholar
PubMed
Search for other papers by Eugênia H O Valença in
Google Scholar
PubMed
Search for other papers by Viviane C Campos in
Google Scholar
PubMed
Search for other papers by Manuel H Aguiar-Oliveira in
Google Scholar
PubMed
Introduction Nonalcoholic fatty liver disease (NAFLD) is a manifestation of the metabolic syndrome and is associated with very common conditions such as obesity, type 2 diabetes, hypertension, dyslipidemia, and atherosclerosis (1) . NAFLD includes
Search for other papers by Melinda Kertész in
Google Scholar
PubMed
Search for other papers by Szilárd Kun in
Google Scholar
PubMed
Search for other papers by Eszter Sélley in
Google Scholar
PubMed
Search for other papers by Zsuzsanna Nagy in
Google Scholar
PubMed
Search for other papers by Tamás Kőszegi in
Google Scholar
PubMed
Search for other papers by István Wittmann in
Google Scholar
PubMed
study, the association of subclinical hypothyroidism and complications of type 2 diabetes was proved ( 11 ). Recently, an increased prevalence of nodular thyroid disease in metabolic syndrome has been detected ( 12 ). Moreover, high T3 may predict
Search for other papers by Wang Chengji in
Google Scholar
PubMed
Search for other papers by Fan Xianjin in
Google Scholar
PubMed
-treated T2DM patients failed to prove any protective effect of tight glycemic control ( 11 ). High levels of tPA have been shown to be predictive of future T2DM independent of metabolic syndrome ( 12 , 13 ). Another study showed that tPA and PAI-1 levels
Search for other papers by Martijn J J Finken in
Google Scholar
PubMed
Search for other papers by Aleid J G Wirix in
Google Scholar
PubMed
Search for other papers by Ines A von Rosenstiel-Jadoul in
Google Scholar
PubMed
Search for other papers by Bibian van der Voorn in
Google Scholar
PubMed
Search for other papers by Mai J M Chinapaw in
Google Scholar
PubMed
Search for other papers by Michaela F Hartmann in
Google Scholar
PubMed
Search for other papers by Joana E Kist-van Holthe in
Google Scholar
PubMed
Search for other papers by Stefan A Wudy in
Google Scholar
PubMed
Search for other papers by Joost Rotteveel in
Google Scholar
PubMed
cortisol ( 7 , 8 , 9 ). Furthermore, in childhood obesity, indices of cortisol production were positively associated with components of the metabolic syndrome, that is, a cluster of metabolic abnormalities characterized by abdominal fat distribution
Search for other papers by Line K Johnson in
Google Scholar
PubMed
Morbid Obesity Centre, Department of Nutrition, Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Gynecology, Institute of Clinical Medicine, Department of Endocrinology, Vestfold Hospital Trust, PO Box 2168, 3103 Tønsberg, Norway
Search for other papers by Kirsten B Holven in
Google Scholar
PubMed
Search for other papers by Njord Nordstrand in
Google Scholar
PubMed
Search for other papers by Jan R Mellembakken in
Google Scholar
PubMed
Morbid Obesity Centre, Department of Nutrition, Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Gynecology, Institute of Clinical Medicine, Department of Endocrinology, Vestfold Hospital Trust, PO Box 2168, 3103 Tønsberg, Norway
Search for other papers by Tom Tanbo in
Google Scholar
PubMed
Morbid Obesity Centre, Department of Nutrition, Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Gynecology, Institute of Clinical Medicine, Department of Endocrinology, Vestfold Hospital Trust, PO Box 2168, 3103 Tønsberg, Norway
Search for other papers by Jøran Hjelmesæth in
Google Scholar
PubMed
Introduction Women with polycystic ovarian syndrome (PCOS) are often overweight and have a central fat distribution (1) . It is well known that abdominal obesity is associated with insulin resistance, metabolic syndrome (MS) and increased risk of
Search for other papers by Aneta Gawlik in
Google Scholar
PubMed
Search for other papers by Michael Shmoish in
Google Scholar
PubMed
Search for other papers by Michaela F Hartmann in
Google Scholar
PubMed
Search for other papers by Stefan A Wudy in
Google Scholar
PubMed
Search for other papers by Zbigniew Olczak in
Google Scholar
PubMed
Search for other papers by Katarzyna Gruszczynska in
Google Scholar
PubMed
Search for other papers by Ze’ev Hochberg in
Google Scholar
PubMed
). NAFLD is regarded as the hepatic manifestation of the metabolic syndrome ( 2 ). However, childhood obesity with no NAFLD is also complicated by the metabolic syndrome. Despite the growth of knowledge regarding obesity-related NAFLD in children, we still
Search for other papers by Bharat Kumar in
Google Scholar
PubMed
Search for other papers by Madhukar Mittal in
Google Scholar
PubMed
Search for other papers by Maya Gopalakrishnan in
Google Scholar
PubMed
Search for other papers by Mahendra K Garg in
Google Scholar
PubMed
Search for other papers by Sanjeev Misra in
Google Scholar
PubMed
Tandon N A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India . Diabetes and Metabolic Syndrome 2021 15 407 – 413 . ( https://doi.org/10.1016/j.dsx.2021.01.015 ) 24 Marfella R Paolisso P Sardu C
Search for other papers by Valentina Guarnotta in
Google Scholar
PubMed
Search for other papers by Silvia Lucchese in
Google Scholar
PubMed
Search for other papers by Mariagrazia Irene Mineo in
Google Scholar
PubMed
Search for other papers by Donatella Mangione in
Google Scholar
PubMed
Search for other papers by Renato Venezia in
Google Scholar
PubMed
Search for other papers by Piero Luigi Almasio in
Google Scholar
PubMed
Search for other papers by Carla Giordano in
Google Scholar
PubMed
androgen levels showing an adverse metabolic phenotype, including hyperinsulinism, dyslipidaemia, and augmented risk for metabolic syndrome and diabetes mellitus in adulthood ( 16 ). The aim of the current study was to identify metabolic factors in girls
Search for other papers by Silan Zheng in
Google Scholar
PubMed
Search for other papers by Meifeng Tong in
Google Scholar
PubMed
Search for other papers by Lianqin Dong in
Google Scholar
PubMed
Search for other papers by Chunmin Du in
Google Scholar
PubMed
Search for other papers by Xin Zheng in
Google Scholar
PubMed
Search for other papers by Liying Wang in
Google Scholar
PubMed
Search for other papers by Peiying Huang in
Google Scholar
PubMed
Search for other papers by Wei Liu in
Google Scholar
PubMed
Search for other papers by Mingzhu Lin in
Google Scholar
PubMed
The School of Clinical Medicine, Fujian Medical University, Fuzhou, China
Search for other papers by Changqin Liu in
Google Scholar
PubMed
often presenting menstrual cycle disturbances and hirsutism or acne ( 1 ). Women with PCOS have an increased long-term risk of developing metabolic syndrome (MetS), hypertension, and increasing cardiovascular morbidity and mortality as well as
Search for other papers by Frederique Van de Velde in
Google Scholar
PubMed
Search for other papers by Marlies Bekaert in
Google Scholar
PubMed
Search for other papers by Anja Geerts in
Google Scholar
PubMed
Search for other papers by Anne Hoorens in
Google Scholar
PubMed
Search for other papers by Arsène-Hélène Batens in
Google Scholar
PubMed
Search for other papers by Samyah Shadid in
Google Scholar
PubMed
Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center at the Heinrich-Heine-University Duesseldorf, Leibniz Center for Diabetes Research, Duesseldorf, Germany
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Search for other papers by Margriet Ouwens in
Google Scholar
PubMed
Search for other papers by Yves Van Nieuwenhove in
Google Scholar
PubMed
Search for other papers by Bruno Lapauw in
Google Scholar
PubMed
-Järvinen H Svegliati-Baroni G . From the metabolic syndrome to NAFLD or vice versa? Digestive and Liver Disease 2010 320 – 330 . ( https://doi.org/10.1016/j.dld.2010.01.016 ) 5 Day CP James OFW . Steatohepatitis: a tale of two ‘hits